Literature DB >> 6461696

The occurrence of Strongyloides ratti in the tissues of mice after percutaneous infection.

H J Dawkins, H J Thomason, D I Grove.   

Abstract

The migration of infective larvae of Strongyloides ratti has been examined in C57Bl/6 mice after percutaneous infection of the anterior abdominal wall. Lateral migration of larvae through the skin and subcutaneous tissues was not seen. Large numbers of larvae were recovered from the muscles between 2 and 24 hours after infection and larvae were seen in the cerebrospinal fluid 24 and 48 hours after infection. Insignificant numbers of larvae were seen in the blood, serosal cavities, liver, spleen, kidneys, brain or nasopharynx. Larvae arrived in the lungs between 24 and 72 hours after infection and worms were first noted in the small intestines at 48 hours. It is concluded that larvae migrate preferentially to the muscles and CSF before passing to the lungs, but the exact mode of travel is uncertain.

Entities:  

Mesh:

Year:  1982        PMID: 6461696     DOI: 10.1017/s0022149x00034994

Source DB:  PubMed          Journal:  J Helminthol        ISSN: 0022-149X            Impact factor:   2.170


  4 in total

1.  Transmammary transmission of Strongyloides ratti.

Authors:  M Kawanabe; H Nojima; R Uchikawa
Journal:  Parasitol Res       Date:  1988       Impact factor: 2.289

2.  Regulation of primary Strongyloides ratti infections in mice: a role for interleukin-5.

Authors:  K S Ovington; K McKie; K I Matthaei; I G Young; C A Behm
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

3.  Light and electron microscopical studies of the location of Strongyloides ratti in the mouse intestine.

Authors:  H J Dawkins; T A Robertson; J M Papadimitriou; D I Grove
Journal:  Z Parasitenkd       Date:  1983

4.  Eosinophils and Neutrophils Eliminate Migrating Strongyloides ratti Larvae at the Site of Infection in the Context of Extracellular DNA Trap Formation.

Authors:  Alexandra Ehrens; Nikolas Rüdiger; Lennart Heepmann; Lara Linnemann; Wiebke Hartmann; Marc P Hübner; Minka Breloer
Journal:  Front Immunol       Date:  2021-08-12       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.